跳至主要内容
临床试验/JPRN-UMIN000020124
JPRN-UMIN000020124招募中未知

Efficacy of preceding administration of Entecavir with PEG-IFN-alfa2a for patients with chronic hepatitis B, positive with HBe antigen in young aged populations - Efficacy of preceding administration of Entecavir with PEG-IFN-alfa2a for patients with chronic hepatitis B, positive with HBe antigen in young aged populations

Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine,0 个研究点目标入组 26 人开始时间: 2015年12月8日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
26

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 40years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. HCV antibody positive 2. Liver cirrhosis 3. Pregnancy or lactation period 4. Entecavir or interferon therapy before the study 5. Treated with shou-saikotou (Kampo medicine) 6. Past history of interstitial pneumoniae 7. Past history of autoimmune hepatitis 8. Allergy with vaccination 9. Severe mentally disordered, severe psychotic disease 10. Others

研究者

发起方
Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine,

相似试验